A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 63,264 shares of FATE stock, worth $140,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,264
Previous 51,744 22.26%
Holding current value
$140,446
Previous $169,000 30.77%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.12 - $5.57 $35,942 - $64,166
11,520 Added 22.26%
63,264 $221,000
Q2 2024

Aug 14, 2024

BUY
$3.26 - $7.08 $168,685 - $366,347
51,744 New
51,744 $169,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $215M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.